Sarepta Therapeutics reported $221.19M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US USD 5.84M 483K
Agios Pharmaceuticals AGIO:US USD 5.18M 1.12M
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Amgen AMGN:US USD 4.93B 173M
Biogen BIIB:US USD 1.38B 80.8M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Daiichi Sankyo 4568:JP JPY 266.68B 4.56B
Esperion Therapeutics ESPR:US USD 29.54M 313K
Gilead Sciences GILD:US USD 2.82B 218M
Insmed INSM:US USD 66.28M 741K
IONIS PHARMACEUT IONS:US USD 20.64M 834K
Moderna Inc MRNA:US USD 2.08B 156M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Novavax NVAX:US USD 82.43M 173.87M
Ptc Therapeutics PTCT:US USD 14.81M 192K
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Roche Holding ROG:VX 8.29B 577M
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M
YTE INCY:US USD 45.87M 8.63M